In-silico design of a new multi-epitope vaccine candidate against SARS-CoV-2
Frequent, and sometimes more dangerous, mutations in SARS-CoV-2 indicate that a stronger strategy is needed to produce an effective vaccine—a vaccine that contains a wider range of virus factors and remains effective if one or more mutations have occurred in a part of the genome. In this study, four...
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado em: |
Frontiers Media S.A.
2024-01-01
|
| Colecção: | Acta Virologica |
| Assuntos: | |
| Acesso em linha: | https://www.frontierspartnerships.org/articles/10.3389/av.2023.12481/full |